Editorial

Cystic Fibrosis and COVID-19

Authors: Kyle D. Chapman, MD, Kathryn S. Moffett, MD

Abstract

In the early days of the coronavirus disease 2019 (COVID-19) pandemic, most of the specialists caring for patients with cystic fibrosis (CF) feared for the worst while waiting for more evidence to better characterize the natural history of the disease. Any emerging pathogen could spell trouble for patients with chronic lung disease, but a rapidly spreading respiratory virus with no proven treatments was especially concerning. As more data emerged from China and later Italy, the concern for the potential impact on patients with CF continued to grow. Although the disease caused by severe acute respiratory syndrome-coronavirus-2 is hard on older adults, younger adults are not spared.
Posted in: Pulmonary Disease18

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Felsenstein S, Herbert JA, McNamara PS, et al. COVID-19: immunology and treatment options. Clin Immunol 2020;215:108448. 2. Marshall BC, Lomas P. Weekly COVID-19 Update [Cystic Fibrosis Foundation web site]. 2020. Available at: https://my.cff.org/cfx-docrep/. Accessed June 4, 2020. 3. Coronavirus Resource Center. COVID-19 United States Cases by County [database online]. Baltimore, MD: Johns Hopkins University and Medicine, 2020. Updated July 15, 2020. Available at: https://coronavirus.jhu.edu/us-map. Accessed August 4, 2020. 4. Colombo C, Burgel PR, Gartner S, et al. Impact of COVID-19 on people with cystic fibrosis. Lancet Respir Med 2020;8:e35–e36. 5. Saiman L, Siegel JD, LiPuma JJ, et al. Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol 2014;35(suppl 1):S1–S67. 6. Dasenbrook E. Keep cystic fibrosis patients out of the hospital. Cleve Clin J Med 2020 May 5 [published ahead of print]. 7. Ramos KJ, Pilewski JM, Faro A, et al. Improved prognosis in cystic fibrosis: consideration for intensive care during the COVID-19 pandemic. Am J Respir Crit Care Med 2020;201:1434–1435. 8. Cosgriff R, Ahern S, Bell SC, et al. A multinational report to characterise SARSCoV-2 infection in people with cystic fibrosis. J Cyst Fibros 2020;19:355–358.